Emcure Pharma gets relief in $950-million lawsuit

The US district judge James Robart upheld the Indian drug maker's argument that the court lacked jurisdiction over the company and dismissed the case without prejudice, which means it can be refiled.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kjxqfYO
via IFTTT